 | • レポートコード：MRC2-11QY00747 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はクローン病治療薬のグローバル市場について調査・分析したレポートです。種類別（アミノサリチル酸（5-ASA）、コルチコステロイド、免疫調節剤、抗生物質）市場規模、用途別（寛解達成（症状欠如）、寛解維持（再燃予防）、小児クローン病）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別クローン病治療薬の競争状況、市場シェア ・世界のクローン病治療薬市場：種類別市場規模 2015年-2020年（アミノサリチル酸（5-ASA）、コルチコステロイド、免疫調節剤、抗生物質） ・世界のクローン病治療薬市場：種類別市場規模予測 2021年-2026年（アミノサリチル酸（5-ASA）、コルチコステロイド、免疫調節剤、抗生物質） ・世界のクローン病治療薬市場：用途別市場規模 2015年-2020年（寛解達成（症状欠如）、寛解維持（再燃予防）、小児クローン病） ・世界のクローン病治療薬市場：用途別市場規模予測 2021年-2026年（寛解達成（症状欠如）、寛解維持（再燃予防）、小児クローン病） ・北米のクローン病治療薬市場分析：米国、カナダ ・ヨーロッパのクローン病治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのクローン病治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のクローン病治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのクローン病治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie、Janssen Biotech、UCB、Amgen、Tillotts Pharma、Takeda Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Crohn’s Disease Drug Market
The global Crohn’s Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Crohn’s Disease Drug Scope and Market Size
Crohn’s Disease Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Crohn’s Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Crohn’s Disease Drug market is segmented into
Aminosalicylates (5-ASA)
Corticosteroids
Immunomodulators
Antibiotics
Segment by Application, the Crohn’s Disease Drug market is segmented into
Achieving Remission (The Absence Of Symptoms)
Maintaining Remission (Prevention Of Flare-Ups)
Pediatric Crohn’S Disease
Regional and Country-level Analysis
The Crohn’s Disease Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Crohn’s Disease Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Crohn’s Disease Drug Market Share Analysis
Crohn’s Disease Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Crohn’s Disease Drug business, the date to enter into the Crohn’s Disease Drug market, Crohn’s Disease Drug product introduction, recent developments, etc.
The major vendors covered:
AbbVie
Janssen Biotech
UCB
Amgen
Tillotts Pharma
Takeda Pharmaceuticals
…
1 Study Coverage
1.1 Crohn’s Disease Drug Product Introduction
1.2 Market Segments
1.3 Key Crohn’s Disease Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Crohn’s Disease Drug Market Size Growth Rate by Type
1.4.2 Aminosalicylates (5-ASA)
1.4.3 Corticosteroids
1.4.4 Immunomodulators
1.4.5 Antibiotics
1.5 Market by Application
1.5.1 Global Crohn’s Disease Drug Market Size Growth Rate by Application
1.5.2 Achieving Remission (The Absence Of Symptoms)
1.5.3 Maintaining Remission (Prevention Of Flare-Ups)
1.5.4 Pediatric Crohn’S Disease
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Crohn’s Disease Drug Market Size, Estimates and Forecasts
2.1.1 Global Crohn’s Disease Drug Revenue 2015-2026
2.1.2 Global Crohn’s Disease Drug Sales 2015-2026
2.2 Global Crohn’s Disease Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Crohn’s Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Crohn’s Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Crohn’s Disease Drug Competitor Landscape by Players
3.1 Crohn’s Disease Drug Sales by Manufacturers
3.1.1 Crohn’s Disease Drug Sales by Manufacturers (2015-2020)
3.1.2 Crohn’s Disease Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Crohn’s Disease Drug Revenue by Manufacturers
3.2.1 Crohn’s Disease Drug Revenue by Manufacturers (2015-2020)
3.2.2 Crohn’s Disease Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Crohn’s Disease Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Crohn’s Disease Drug Revenue in 2019
3.2.5 Global Crohn’s Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Crohn’s Disease Drug Price by Manufacturers
3.4 Crohn’s Disease Drug Manufacturing Base Distribution, Product Types
3.4.1 Crohn’s Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Crohn’s Disease Drug Product Type
3.4.3 Date of International Manufacturers Enter into Crohn’s Disease Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Crohn’s Disease Drug Market Size by Type (2015-2020)
4.1.1 Global Crohn’s Disease Drug Sales by Type (2015-2020)
4.1.2 Global Crohn’s Disease Drug Revenue by Type (2015-2020)
4.1.3 Crohn’s Disease Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Crohn’s Disease Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Crohn’s Disease Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Crohn’s Disease Drug Revenue Forecast by Type (2021-2026)
4.2.3 Crohn’s Disease Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Crohn’s Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Crohn’s Disease Drug Market Size by Application (2015-2020)
5.1.1 Global Crohn’s Disease Drug Sales by Application (2015-2020)
5.1.2 Global Crohn’s Disease Drug Revenue by Application (2015-2020)
5.1.3 Crohn’s Disease Drug Price by Application (2015-2020)
5.2 Crohn’s Disease Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Crohn’s Disease Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Crohn’s Disease Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Crohn’s Disease Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Crohn’s Disease Drug by Country
6.1.1 North America Crohn’s Disease Drug Sales by Country
6.1.2 North America Crohn’s Disease Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Crohn’s Disease Drug Market Facts & Figures by Type
6.3 North America Crohn’s Disease Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Crohn’s Disease Drug by Country
7.1.1 Europe Crohn’s Disease Drug Sales by Country
7.1.2 Europe Crohn’s Disease Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Crohn’s Disease Drug Market Facts & Figures by Type
7.3 Europe Crohn’s Disease Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Crohn’s Disease Drug by Region
8.1.1 Asia Pacific Crohn’s Disease Drug Sales by Region
8.1.2 Asia Pacific Crohn’s Disease Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Crohn’s Disease Drug Market Facts & Figures by Type
8.3 Asia Pacific Crohn’s Disease Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Crohn’s Disease Drug by Country
9.1.1 Latin America Crohn’s Disease Drug Sales by Country
9.1.2 Latin America Crohn’s Disease Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Crohn’s Disease Drug Market Facts & Figures by Type
9.3 Central & South America Crohn’s Disease Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Crohn’s Disease Drug by Country
10.1.1 Middle East and Africa Crohn’s Disease Drug Sales by Country
10.1.2 Middle East and Africa Crohn’s Disease Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Crohn’s Disease Drug Market Facts & Figures by Type
10.3 Middle East and Africa Crohn’s Disease Drug Market Facts & Figures by Application
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description and Business Overview
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Crohn’s Disease Drug Products Offered
11.1.5 AbbVie Related Developments
11.2 Janssen Biotech
11.2.1 Janssen Biotech Corporation Information
11.2.2 Janssen Biotech Description and Business Overview
11.2.3 Janssen Biotech Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Janssen Biotech Crohn’s Disease Drug Products Offered
11.2.5 Janssen Biotech Related Developments
11.3 UCB
11.3.1 UCB Corporation Information
11.3.2 UCB Description and Business Overview
11.3.3 UCB Sales, Revenue and Gross Margin (2015-2020)
11.3.4 UCB Crohn’s Disease Drug Products Offered
11.3.5 UCB Related Developments
11.4 Amgen
11.4.1 Amgen Corporation Information
11.4.2 Amgen Description and Business Overview
11.4.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Amgen Crohn’s Disease Drug Products Offered
11.4.5 Amgen Related Developments
11.5 Tillotts Pharma
11.5.1 Tillotts Pharma Corporation Information
11.5.2 Tillotts Pharma Description and Business Overview
11.5.3 Tillotts Pharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Tillotts Pharma Crohn’s Disease Drug Products Offered
11.5.5 Tillotts Pharma Related Developments
11.6 Takeda Pharmaceuticals
11.6.1 Takeda Pharmaceuticals Corporation Information
11.6.2 Takeda Pharmaceuticals Description and Business Overview
11.6.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Takeda Pharmaceuticals Crohn’s Disease Drug Products Offered
11.6.5 Takeda Pharmaceuticals Related Developments
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description and Business Overview
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Crohn’s Disease Drug Products Offered
11.1.5 AbbVie Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Crohn’s Disease Drug Market Estimates and Projections by Region
12.1.1 Global Crohn’s Disease Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Crohn’s Disease Drug Revenue Forecast by Regions 2021-2026
12.2 North America Crohn’s Disease Drug Market Size Forecast (2021-2026)
12.2.1 North America: Crohn’s Disease Drug Sales Forecast (2021-2026)
12.2.2 North America: Crohn’s Disease Drug Revenue Forecast (2021-2026)
12.2.3 North America: Crohn’s Disease Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Crohn’s Disease Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Crohn’s Disease Drug Sales Forecast (2021-2026)
12.3.2 Europe: Crohn’s Disease Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Crohn’s Disease Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Crohn’s Disease Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Crohn’s Disease Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Crohn’s Disease Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Crohn’s Disease Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Crohn’s Disease Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Crohn’s Disease Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Crohn’s Disease Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Crohn’s Disease Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Crohn’s Disease Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Crohn’s Disease Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Crohn’s Disease Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Crohn’s Disease Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Crohn’s Disease Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Crohn’s Disease Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Crohn’s Disease Drug Market Segments
Table 2. Ranking of Global Top Crohn’s Disease Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Crohn’s Disease Drug Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Aminosalicylates (5-ASA)
Table 5. Major Manufacturers of Corticosteroids
Table 6. Major Manufacturers of Immunomodulators
Table 7. Major Manufacturers of Antibiotics
Table 8. Global Crohn’s Disease Drug Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Crohn’s Disease Drug Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Crohn’s Disease Drug Sales by Regions 2015-2020 (K MT)
Table 11. Global Crohn’s Disease Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Crohn’s Disease Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Crohn’s Disease Drug Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Crohn’s Disease Drug Sales Share by Manufacturers (2015-2020)
Table 15. Global Crohn’s Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Crohn’s Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn’s Disease Drug as of 2019)
Table 17. Crohn’s Disease Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Crohn’s Disease Drug Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Crohn’s Disease Drug Price (2015-2020) (USD/MT)
Table 20. Crohn’s Disease Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Crohn’s Disease Drug Product Type
Table 22. Date of International Manufacturers Enter into Crohn’s Disease Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Crohn’s Disease Drug Sales by Type (2015-2020) (K MT)
Table 25. Global Crohn’s Disease Drug Sales Share by Type (2015-2020)
Table 26. Global Crohn’s Disease Drug Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Crohn’s Disease Drug Revenue Share by Type (2015-2020)
Table 28. Crohn’s Disease Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Crohn’s Disease Drug Sales by Application (2015-2020) (K MT)
Table 30. Global Crohn’s Disease Drug Sales Share by Application (2015-2020)
Table 31. North America Crohn’s Disease Drug Sales by Country (2015-2020) (K MT)
Table 32. North America Crohn’s Disease Drug Sales Market Share by Country (2015-2020)
Table 33. North America Crohn’s Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Crohn’s Disease Drug Revenue Market Share by Country (2015-2020)
Table 35. North America Crohn’s Disease Drug Sales by Type (2015-2020) (K MT)
Table 36. North America Crohn’s Disease Drug Sales Market Share by Type (2015-2020)
Table 37. North America Crohn’s Disease Drug Sales by Application (2015-2020) (K MT)
Table 38. North America Crohn’s Disease Drug Sales Market Share by Application (2015-2020)
Table 39. Europe Crohn’s Disease Drug Sales by Country (2015-2020) (K MT)
Table 40. Europe Crohn’s Disease Drug Sales Market Share by Country (2015-2020)
Table 41. Europe Crohn’s Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Crohn’s Disease Drug Revenue Market Share by Country (2015-2020)
Table 43. Europe Crohn’s Disease Drug Sales by Type (2015-2020) (K MT)
Table 44. Europe Crohn’s Disease Drug Sales Market Share by Type (2015-2020)
Table 45. Europe Crohn’s Disease Drug Sales by Application (2015-2020) (K MT)
Table 46. Europe Crohn’s Disease Drug Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Crohn’s Disease Drug Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Crohn’s Disease Drug Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Crohn’s Disease Drug Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Crohn’s Disease Drug Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Crohn’s Disease Drug Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Crohn’s Disease Drug Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Crohn’s Disease Drug Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Crohn’s Disease Drug Sales Market Share by Application (2015-2020)
Table 55. Latin America Crohn’s Disease Drug Sales by Country (2015-2020) (K MT)
Table 56. Latin America Crohn’s Disease Drug Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Crohn’s Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Crohn’s Disease Drug Revenue Market Share by Country (2015-2020)
Table 59. Latin America Crohn’s Disease Drug Sales by Type (2015-2020) (K MT)
Table 60. Latin America Crohn’s Disease Drug Sales Market Share by Type (2015-2020)
Table 61. Latin America Crohn’s Disease Drug Sales by Application (2015-2020) (K MT)
Table 62. Latin America Crohn’s Disease Drug Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Crohn’s Disease Drug Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Crohn’s Disease Drug Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Crohn’s Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Crohn’s Disease Drug Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Crohn’s Disease Drug Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Crohn’s Disease Drug Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Crohn’s Disease Drug Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Crohn’s Disease Drug Sales Market Share by Application (2015-2020)
Table 71. AbbVie Corporation Information
Table 72. AbbVie Description and Major Businesses
Table 73. AbbVie Crohn’s Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. AbbVie Product
Table 75. AbbVie Recent Development
Table 76. Janssen Biotech Corporation Information
Table 77. Janssen Biotech Description and Major Businesses
Table 78. Janssen Biotech Crohn’s Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Janssen Biotech Product
Table 80. Janssen Biotech Recent Development
Table 81. UCB Corporation Information
Table 82. UCB Description and Major Businesses
Table 83. UCB Crohn’s Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. UCB Product
Table 85. UCB Recent Development
Table 86. Amgen Corporation Information
Table 87. Amgen Description and Major Businesses
Table 88. Amgen Crohn’s Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Amgen Product
Table 90. Amgen Recent Development
Table 91. Tillotts Pharma Corporation Information
Table 92. Tillotts Pharma Description and Major Businesses
Table 93. Tillotts Pharma Crohn’s Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Tillotts Pharma Product
Table 95. Tillotts Pharma Recent Development
Table 96. Takeda Pharmaceuticals Corporation Information
Table 97. Takeda Pharmaceuticals Description and Major Businesses
Table 98. Takeda Pharmaceuticals Crohn’s Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Takeda Pharmaceuticals Product
Table 100. Takeda Pharmaceuticals Recent Development
Table 101. Global Crohn’s Disease Drug Sales Forecast by Regions (2021-2026) (K MT)
Table 102. Global Crohn’s Disease Drug Sales Market Share Forecast by Regions (2021-2026)
Table 103. Global Crohn’s Disease Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 104. Global Crohn’s Disease Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 105. North America: Crohn’s Disease Drug Sales Forecast by Country (2021-2026) (K MT)
Table 106. North America: Crohn’s Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Europe: Crohn’s Disease Drug Sales Forecast by Country (2021-2026) (K MT)
Table 108. Europe: Crohn’s Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Asia Pacific: Crohn’s Disease Drug Sales Forecast by Region (2021-2026) (K MT)
Table 110. Asia Pacific: Crohn’s Disease Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 111. Latin America: Crohn’s Disease Drug Sales Forecast by Country (2021-2026) (K MT)
Table 112. Latin America: Crohn’s Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Middle East and Africa: Crohn’s Disease Drug Sales Forecast by Country (2021-2026) (K MT)
Table 114. Middle East and Africa: Crohn’s Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 116. Key Challenges
Table 117. Market Risks
Table 118. Main Points Interviewed from Key Crohn’s Disease Drug Players
Table 119. Crohn’s Disease Drug Customers List
Table 120. Crohn’s Disease Drug Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Crohn’s Disease Drug Product Picture
Figure 2. Global Crohn’s Disease Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Aminosalicylates (5-ASA) Product Picture
Figure 4. Corticosteroids Product Picture
Figure 5. Immunomodulators Product Picture
Figure 6. Antibiotics Product Picture
Figure 7. Global Crohn’s Disease Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Achieving Remission (The Absence Of Symptoms)
Figure 9. Maintaining Remission (Prevention Of Flare-Ups)
Figure 10. Pediatric Crohn'S Disease
Figure 11. Crohn’s Disease Drug Report Years Considered
Figure 12. Global Crohn’s Disease Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Crohn’s Disease Drug Sales 2015-2026 (K MT)
Figure 14. Global Crohn’s Disease Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Crohn’s Disease Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Crohn’s Disease Drug Sales Market Share by Region in 2019
Figure 17. Global Crohn’s Disease Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Crohn’s Disease Drug Revenue Market Share by Region in 2019
Figure 19. Global Crohn’s Disease Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Crohn’s Disease Drug Revenue in 2019
Figure 21. Crohn’s Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Crohn’s Disease Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Crohn’s Disease Drug Sales Market Share by Type in 2019
Figure 24. Global Crohn’s Disease Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Crohn’s Disease Drug Revenue Market Share by Type in 2019
Figure 26. Global Crohn’s Disease Drug Market Share by Price Range (2015-2020)
Figure 27. Global Crohn’s Disease Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Crohn’s Disease Drug Sales Market Share by Application in 2019
Figure 29. Global Crohn’s Disease Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Crohn’s Disease Drug Revenue Market Share by Application in 2019
Figure 31. North America Crohn’s Disease Drug Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Crohn’s Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Crohn’s Disease Drug Sales Market Share by Country in 2019
Figure 34. North America Crohn’s Disease Drug Revenue Market Share by Country in 2019
Figure 35. U.S. Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Crohn’s Disease Drug Market Share by Type in 2019
Figure 40. North America Crohn’s Disease Drug Market Share by Application in 2019
Figure 41. Europe Crohn’s Disease Drug Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Crohn’s Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Crohn’s Disease Drug Sales Market Share by Country in 2019
Figure 44. Europe Crohn’s Disease Drug Revenue Market Share by Country in 2019
Figure 45. Germany Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Crohn’s Disease Drug Market Share by Type in 2019
Figure 56. Europe Crohn’s Disease Drug Market Share by Application in 2019
Figure 57. Asia Pacific Crohn’s Disease Drug Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Crohn’s Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Crohn’s Disease Drug Sales Market Share by Region in 2019
Figure 60. Asia Pacific Crohn’s Disease Drug Revenue Market Share by Region in 2019
Figure 61. China Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Crohn’s Disease Drug Market Share by Type in 2019
Figure 84. Asia Pacific Crohn’s Disease Drug Market Share by Application in 2019
Figure 85. Latin America Crohn’s Disease Drug Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Crohn’s Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Crohn’s Disease Drug Sales Market Share by Country in 2019
Figure 88. Latin America Crohn’s Disease Drug Revenue Market Share by Country in 2019
Figure 89. Mexico Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Crohn’s Disease Drug Market Share by Type in 2019
Figure 96. Latin America Crohn’s Disease Drug Market Share by Application in 2019
Figure 97. Middle East and Africa Crohn’s Disease Drug Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Crohn’s Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Crohn’s Disease Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Crohn’s Disease Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Crohn’s Disease Drug Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Crohn’s Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Crohn’s Disease Drug Market Share by Type in 2019
Figure 108. Middle East and Africa Crohn’s Disease Drug Market Share by Application in 2019
Figure 109. North America Crohn’s Disease Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Crohn’s Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Crohn’s Disease Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Crohn’s Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Crohn’s Disease Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Crohn’s Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Crohn’s Disease Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Crohn’s Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Crohn’s Disease Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Crohn’s Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
クローン病の世界市場（～2026年） Crohn’s disease refers to long term inflammatory bowel disease, which causes inflammation of the lining of the digestive tract. It affects the large and small intestine and is generally diagnosed in persons within the age group of 20-29. It can have severe or acute outcomes. Signs and symptoms of Cr…- クローン病診断・治療の世界市場（～2026年） Crohn's disease is a type of inflammatory bowel disease (IBD) that may affect any part of the gastrointestinal tract from mouth to anus. Signs and symptoms often include abdominal pain, diarrhea, fever, and weight loss. As the prevalence of the disease increases, it is expected to drive the Crohn's …
- 性感染症（STD）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Sexually Transmitted Disease (STD ) Drug Market The global Sexually Transmitted Disease (STD ) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Sexually Transmitted Disease (STD…
- ベーチェット病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Behcet Disease Drug Market The global Behcet Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Behcet Disease Drug Scope and Market Size Behcet Disease Drug market is seg…
- シャルコー・マリー・トゥース病IA型治療薬の世界市場（～2026年） Market Analysis and Insights: Global Charcot-Marie-Tooth Disease Type I A Drug Market The global Charcot-Marie-Tooth Disease Type I A Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Charcot-Marie-Tooth Disease Typ…